Results 11 to 20 of about 47,373 (236)
Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia
Neuropsychopharmacology Reports, 2022 Aripiprazole long‐acting injection (LAI) is approved for the treatment of schizophrenia in adults. Recently, Europe and Canada approved the use of the two‐injection start regimen: two separate injections of 400‐mg long‐acting aripiprazole along with a ...
V. Salvi +4 more
semanticscholar +1 more source
A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
Case Reports in Psychiatry, 2021 Aripiprazole is an antipsychotic with partial agonist activity at the dopamine D2 receptor which may lead to compulsive behaviors including hypersexuality.
Lakshmi Priya, Bini Moorthy
doaj +1 more source
Pharmacogenomic testing and its future in community pharmacy [PDF]
, 2020 Although it is common to see pharmacogenomic testing used North America and Australia, it is not yet part of practice in the UK. With the promise of genomic screening becoming part of the NHS, pharmacists must equip themselves with a knowledge of how the
Wright, David, Youssef, Essra
core +1 more source
Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study
Children, 2021 Risperidone and aripiprazole are approved by the USA Food and Drug Administration for the treatment of irritability and aggression in children from the ages of 5 and 6 years, respectively.
H. Alsayouf +3 more
semanticscholar +1 more source
International Journal of Molecular Sciences, 2021 Microglial cells are resident macrophages in the brain that have been implicated in the pathophysiology of schizophrenia. There is a lack of studies covering the effects of antipsychotics on microglial cells.
Valentino Rački +4 more
semanticscholar +1 more source
Frontiers in Neuroscience, 2023 Many patients with psychiatric conditions, such as bipolar disorder and major depressive disorder, frequently experience disruptions in their sleep–wake cycles.
Ruoshi Li +10 more
doaj +1 more source
Clinical Pharmacokinetics, 2021 Aripiprazole is an atypical antipsychotic drug that is metabolized by cytochrome P450 (CYP) 2D6 and CYP3A4, which mainly form its active metabolite dehydro-aripiprazole.
L. A. Kneller +4 more
semanticscholar +1 more source
Frontiers in Psychiatry, 2022 ObjectiveTo study the similarities and differences in the clinical efficacy of aripiprazole and quetiapine in Chinese patients with bipolar depression through meta-analysis.
Hejian Tao +6 more
doaj +1 more source
Current Medical Research and Opinion, 2021 Background The single-injection start regimen for aripiprazole once-monthly 400 mg (AOM 400) in patients with schizophrenia requires a single intramuscular injection in the gluteal or deltoid site and 14 days of concurrent oral therapy.
Yanlin Wang +11 more
semanticscholar +1 more source
Frontiers in Psychiatry, 2021 Aripiprazole, metformin, and paeoniae–glycyrrhiza decoction (PGD) have been widely used as adjunctive treatments to reduce antipsychotic (AP)-induced hyperprolactinemia in patients with schizophrenia. However, the comparative efficacy and safety of these
Ling Zhang +8 more
semanticscholar +1 more source